Big movements in Zomedica Pharmaceuticals Corp stock price on Thursday moving 11.84% between high and low

The Zomedica Pharmaceuticals Corp stock price fell by -7.71% on the last day (Thursday, 12th Aug 2021) from $0.56 to $0.52. and has now fallen 6 days in a row. During the day the stock fluctuated 11.84% from a day low at $0.49 to a day high of $0.55. The price has fallen in 8 of the last 10 days and is down by -14.82% for this period. Volume has increased on the last day by 26 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 42 million shares were bought and sold for approximately $21.60 million.

HC Wainwright is very positive about ZOM and gave it a "Buy" rating on November 16, 2020. The price target was changed from $0.50 to $0.30.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.Given the current short-term trend, the stock is expected to fall -31.42% during the next 3 months and, with a 90% probability hold a price between $0.27 and $0.50 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Zomedica Pharmaceuticals Corp stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.57 and $0.67. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 08, 2021, and so far it has fallen -46.46%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0580 between high and low, or 11.84%. For the last week, the stock has had a daily average volatility of 5.60%.

Zomedica Pharmaceuticals Corp holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.